Product overview
Type
Malaria
Commercial Name
Mosquirix
Manufacturer
GlaxoSmithKline Biologicals SA
URL
Responsible NRA
European Medicines Agency
Country
Netherlands
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Two vial set (active + active)
Number of Doses
2
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
Carton of 50 vials (powder) and 50 vials (suspension) (100 doses). Dimensions: 14.9 x 18.0 x 3.7 cm
Tertiary Packaging
Shipping box containing twenty-four secondary cartons (2x1200 vials / 2400 doses). Dimensions: 34.2 x 25.1 x 43.1 cm
Multidose Vial Policy
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Vaccine Preservative
none
Cold Chain Volume
9.92 cm3/dose (in secondary packaging)